Dutasteride And Tamsulosin Hydrochloride Capsule
Product Images NDC 59651-063

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dutasteride And Tamsulosin Hydrochloride (NDC 59651-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. International Prostate Symptom Score Change From Baseline Over A 48-month Period (randomized, Double-blind, Parallel-group Trial [combat Trial]) (Dutatamsulosin Fig1)

A line chart depicting mean change from baseline in IPSS (International Prostate Symptom Score) over 48 months of treatment. The graph compares three groups: Dutasteride + Tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg, with patient numbers around 1,575 in each group. The x-axis shows months of treatment, and the y-axis shows mean change in IPSS scores.*

FDA Label Image

Figure2 (Dutatamsulosin Fig2)

A line graph showing mean change from baseline in a variable over 24 months of treatment for Dutasteride + Tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg groups. The x-axis represents months of treatment (0 to 24), and the y-axis shows mean change values. Data points for each treatment group are connected by lines, with sample sizes noted at 6, 12, 18, and 24 months.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg/0.4 mg (30 Capsules Bottle))

Label for Dutasteride and Tamsulosin Hydrochloride Capsules, USP 0.5 mg/0.4 mg oral capsules by Aurobindo Pharma Limited. The label states the NDC 59651-063-30 and shows storage instructions, dosage information, and a warning for use in women and children. The package contains 30 capsules and is distributed by Aurobindo Pharma USA, Inc., made in India. A barcode is present along the right side.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg/0.4 mg (90 Capsules Bottle))

Dutasteride and Tamsulosin Hydrochloride Capsules USP 0.5 mg/0.4 mg label for 90 capsules by Aurobindo Pharma Limited. The label lists each capsule's active ingredients, dosage instructions, storage conditions, and warnings. It includes the product NDC 59651-063-90, distributor details (Aurobindo Pharma USA, Inc.), and a barcode. Safety warnings specify the product is not for women or children and advise against use if the safety seal under the cap is broken or missing.*

FDA Label Image

Chemical Structure 1 (Dutatamsulosin Str1)

Chemical structure diagram of Dutasteride, showing its steroid backbone with trifluoromethyl phenyl group and relevant functional groups.*

FDA Label Image

Chemical Structure 2 (Dutatamsulosin Str2)

Chemical structure diagram of Dutasteride and Tamsulosin Hydrochloride, showing molecular components and bonds, including a hydrochloride (HCl) moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.